Weight loss dynamics during combined fluoxetine and olanzapine treatment
about
Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays.Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression.Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses.
P2860
Weight loss dynamics during combined fluoxetine and olanzapine treatment
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@ast
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@en
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@nl
type
label
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@ast
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@en
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@nl
prefLabel
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@ast
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@en
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@nl
P2093
P2860
P356
P1433
P1476
Weight loss dynamics during combined fluoxetine and olanzapine treatment
@en
P2093
Brian H Hallas
German Torres
Janet M Chabla
Jennifer A Perrone
Judith M Horowitz
P2860
P2888
P356
10.1186/1471-2210-4-27
P407
P577
2004-10-21T00:00:00Z
P5875
P6179
1014823012